Get the Stockscreener App
9.17
0.11%
0.010
Optinose Inc stock is traded at $9.17, with a volume of 19,070.
It is up +0.11% in the last 24 hours and up +55.95% over the past month.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
See More
Previous Close:
$9.16
Open:
$9.21
24h Volume:
19,070
Relative Volume:
0.20
Market Cap:
$92.16M
Revenue:
$75.67M
Net Income/Loss:
$-31.15M
P/E Ratio:
-33.02
EPS:
-0.2777
Net Cash Flow:
$-39.79M
1W Performance:
+1.33%
1M Performance:
+55.95%
6M Performance:
-18.49%
1Y Performance:
-40.07%
1-Day Range:
$9.15
$9.24
1-Week Range:
$9.00
$9.28
52-Week Range:
$4.815
$20.02
Optinose Inc Stock (OPTN) Company Profile
Name
Optinose Inc
Sector
Phone
267-364-3500
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Compare OPTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
9.17 | 92.16M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Downgrade | Lake Street | Buy → Hold |
| Jan-03-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-11-24 | Initiated | H.C. Wainwright | Buy |
| Aug-21-23 | Initiated | Lake Street | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-19 | Initiated | Cowen | Outperform |
| Aug-08-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Optinose Inc Stock (OPTN) Latest News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSEAZEK), Mesa Air Group, Inc. (NasdaqMESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (NasdaqOPTN) - Morningstar
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek - BUCKSCO.Today
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal - The Business Journals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
When (OPTN) Moves Investors should Listen - news.stocktradersdaily.com
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerOPTN, SLRN, AKYA, SHYF - Lelezard
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN - Bluefield Daily Telegraph
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, COOP, OPTN, RDFN on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mr. Cooper Group Inc. (Nasdaq – COOP), Beacon Roofing Supply, Inc. (NasdaqBECN), Optinose, Inc. (NasdaqOPTN), Redfin Corporation (NasdaqRDFN - TradingView
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN) - Defense World
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income - MyChesCo
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates - MSN
OptiNose earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
OptiNose: Q4 Earnings Snapshot - The Washington Post
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings - Nasdaq
OptiNose Q4 Net Loss Narrows - Nasdaq
OptiNose Q4 Income From Operations USD 354 Thousand - MarketScreener
OptiNose Inc. Q4 Loss Decreases, Beats Estimates - Nasdaq
Philly weekly roundup: Proscia's $50M raise; Optinose acquired; A new biotech startup incubator - Technical.ly
Wall Street Analysts Believe OptiNose (OPTN) Could Rally 143.06%: Here's is How to Trade - Yahoo Finance
Paratek Pharmaceuticals’ Acquisition of Optinose - Global Legal Chronicle
Piper Sandler Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
HC Wainwright Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Cut to “Hold” at Piper Sandler - Defense World
OptiNose (NASDAQ:OPTN) Rating Lowered to “Hold” at Lake Street Capital - Defense World
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Earnings To Watch: OptiNose Inc (OPTN) Reports Q4 2024 Result - GuruFocus
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek - MSN
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal - BUCKSCO.Today
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce - Simply Wall St
Why OptiNose Inc. (OPTN) Surged On Thursday? - Insider Monkey
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news - Investorsobserver
Darden Restaurants, Nike, Optinose - TradingView
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight - Asianet Newsable
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
Lake Street cuts Optinose stock rating, lowers target to $9 By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc.OPTN - The Malaysian Reserve
Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics - insights.citeline.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders - The Malaysian Reserve
Sector Update: Health Care Stocks Mixed in Afternoon Trading -March 20, 2025 at 02:03 pm EDT - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX) - TradingView
Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal - The Business Journals
Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target -March 20, 2025 at 12:32 pm EDT - Marketscreener.com
Paratek to buy Optinose for up to $330 million - The Pharma Letter
Optinose Inc Stock (OPTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):